Articles & Issues

Alert me when new Articles in Press are available. Add Articles in Press Alert   Request Articles in Press Alert via email or RSS Feed   Request RSS feed of Articles in Press

23 Articles

  • 1
Article Title Author(s) Type (Status) Available Online
The Role of IMiDs Alone or in Combination in Prostate Cancer

DOI: 10.1016/j.clgc.2012.03.005

Chadi Nabhan, Daniel P. Petrylak Review article
(In Press Corrected Proof)
21 May 2012
Neutrophil Number after Interferon-Alfa Treatment is an Independent Predictive Marker of Overall Survival in Metastatic Renal Cell Carcinoma

DOI: 10.1016/j.clgc.2012.03.006

Takeshi Azuma, Yukihide Matayoshi, Yasushi Nagase, Masaya Oshi Full-length article
(In Press Corrected Proof)
21 May 2012
Prolonged Therapy With Cabazitaxel in an Octogenarian With Metastatic Castration-Resistant Prostate Cancer

DOI: 10.1016/j.clgc.2012.03.007

Sumanta K. Pal, Cy A. Stein Short communication
(In Press Corrected Proof)
11 May 2012
A Phase II Trial of Intrapatient Dose-Escalated Sorafenib in Patients With Metastatic Renal Cell Carcinoma

DOI: 10.1016/j.clgc.2012.03.001

Robert Amato, Jim Zhai, James Willis, Somyata Saxena, Melissa DeFoe et al. Full-length article
(In Press Corrected Proof)
03 May 2012
Metastatic Extraosseous Ewing's Sarcoma (EES)/Primitive Neuroectodermal Tumor (PNET) of the Kidney: 8-Year Durable Response After Induction and Maintenance Chemotherapy

DOI: 10.1016/j.clgc.2012.03.004

Stephen L. Richey, Priya Rao, Christopher G. Wood, Shreyaskumar Patel, Nizar M. Tannir et al. Short communication
(In Press Corrected Proof)
16 April 2012
A Randomized Trial Comparing Tamoxifen Therapy vs. Tamoxifen Prophylaxis in Bicalutamide-Induced Gynecomastia

DOI: 10.1016/j.clgc.2012.03.002

Vincenzo Serretta, Vincenzo Altieri, Giuseppe Morgia, Federico Nicolosi, Gaetano De Grande, Rosaria Mazza, Darwin Melloni, Rosalinda Allegro, Francesco Ferraù, Vittorio Gebbia et al. Full-length article
(In Press Corrected Proof)
13 April 2012
Malignant Fibrous Histiocytoma of the Spermatic Cord in a Patient With Polycystic Kidney Disease; Review of the Literature

DOI: 10.1016/j.clgc.2012.03.003

Lutfiye Demir, Alper Can, Ahmet Dirican, Vedat Bayoğlu, Turkan Atasever Rezanko, Murat Akyol, Yuksel Kucukzeybek, Cigdem Erten, Mustafa Oktay Tarhan et al. Short communication
(In Press Corrected Proof)
09 April 2012
Cabazitaxel Rechallenge at Prostate-Specific Antigen Relapse After Previous Cabazitaxel and Docetaxel Chemotherapy: Case Report

DOI: 10.1016/j.clgc.2012.01.011

Christina J. Perry, Santhanam Sundar Short communication
(In Press Corrected Proof)
26 March 2012
Enduring Response to Everolimus as Third-Line Therapy in a Patient With Advanced Renal Cell Carcinoma, Including Small-Bowel Metastases: Loss of FHIT but Normal VHL Gene Status

DOI: 10.1016/j.clgc.2012.01.008

Reuben J. Broom, Imogen Caldwell, Fritha Hanning, Peter Fong, Sanjeev Deva, Paul Oei et al. Short communication
(In Press Corrected Proof)
22 March 2012
Prostate Cancer Stem Cells

DOI: 10.1016/j.clgc.2012.01.002

Shi-Ming Tu, Sue-Hwa Lin Review article
(In Press Corrected Proof)
16 March 2012
Spontaneous Regression of Thoracic Metastases While Progression of Brain Metastases After Stereotactic Radiosurgery and Stereotactic Body Radiotherapy for Metastatic Renal Cell Carcinoma: Abscopal Effect Prevented by the Blood-Brain Barrier?

DOI: 10.1016/j.clgc.2012.01.004

Hiromichi Ishiyama, Bin S. Teh, Hua Ren, Stephen Chiang, Anne Tann, Angel I. Blanco, Arnold C. Paulino, Robert Amato et al. Short communication
(In Press Corrected Proof)
14 March 2012
A Primary Signet Ring Cell Carcinoma of the Prostate With Bone Metastasis With Impressive Response to FOLFOX and Cetuximab

DOI: 10.1016/j.clgc.2012.01.006

Ana Milena Roldán, Natalia Fernández Núñez, Enrique Grande, Augusto Álvarez García, Luis M. Antón-Aparicio et al. Short communication
(In Press Corrected Proof)
14 March 2012
Development of Novel Immune Interventions for Prostate Cancer

DOI: 10.1016/j.clgc.2012.01.012

Neeraj Agarwal, Sumanth Padmanabh, Nicholas J. Vogelzang Review article
(In Press Corrected Proof)
14 March 2012
Response of Metastatic Renal Medullary Carcinoma to Carboplatinum and Paclitaxel Chemotherapy

DOI: 10.1016/j.clgc.2012.01.003

Venu gopala reddy Gangireddy, Georgia B. Liles, Gilberto D. Sostre, Teresa Coleman Short communication
(In Press Corrected Proof)
14 March 2012
Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer: A Systematic Diagnostic Attempt

DOI: 10.1016/j.clgc.2011.12.004

Deliu-Victor Matei, Giuseppe Renne, Marcelo Pimentel, Maria Teresa Sandri, Laura Zorzino, Edoardo Botteri, Concetta De Cicco, Gennaro Musi, Antonio Brescia, Federica Mazzoleni, Valeria Tringali, Serena Detti, Ottavio de Cobelli et al. Full-length article
(In Press Corrected Proof)
09 March 2012
Prevalence and Predictors of Benign Lesions in Renal Masses Smaller Than 7 cm Presumed to be Renal Cell Carcinoma

DOI: 10.1016/j.clgc.2012.01.005

Bulent Akdogan, Ahmet Gudeloglu, Kubilay Inci, Levent Mert Gunay, Artan Koni, Haluk Ozen et al. Full-length article
(In Press Corrected Proof)
09 March 2012
Phase II Trial of Weekly Ixabepilone in Men With Metastatic Castrate-Resistant Prostate Cancer (E3803): A Trial of the Eastern Cooperative Oncology Group

DOI: 10.1016/j.clgc.2012.01.009

Glenn Liu, Yu-Hui Chen, Robert DiPaola, Michael Carducci, George Wilding et al. Full-length article
(In Press Corrected Proof)
05 March 2012
Expression of microRNAs in the Urine of Patients With Bladder Cancer

DOI: 10.1016/j.clgc.2012.01.001

Gang Wang, Eddie Shu-Yin Chan, Bonnie Ching-Ha Kwan, Philip Kam-Tao Li, Sidney Kam-Hung Yip, Cheuk-Chun Szeto, Chi-Fai Ng et al. Full-length article
(In Press Corrected Proof)
05 March 2012
Ras Association Domain Family 1A: A Promising Prognostic Marker in Recurrent Nonmuscle Invasive Bladder Cancer

DOI: 10.1016/j.clgc.2011.12.003

Ji Sang Kim, Yunbyung Chae, Yun-Sok Ha, Isaac Yi Kim, Seok Soo Byun, Seok-Joong Yun, Wun-Jae Kim et al. Full-length article
(In Press Corrected Proof)
01 March 2012
Importance of Fibroblast Growth Factor Receptor in Neovascularization and Tumor Escape from Antiangiogenic Therapy

DOI: 10.1016/j.clgc.2012.01.010

Philip J. Saylor, Bernard Escudier, M. Dror Michaelson Review article
(In Press Corrected Proof)
01 March 2012
Epidemiologic Trends in Renal Cell Carcinoma in the Cytokine and Post-Cytokine Eras: A Registry Analysis of 28,252 Patients

DOI: 10.1016/j.clgc.2012.01.007

Derek Shek, Benjamin Tomlinson, Monica Brown, Ann Brunson, Chong-Xian Pan, Primo N. Lara et al. Full-length article
(In Press Corrected Proof)
01 March 2012
A Case Report of Putative Autoimmunity to Prostate Cancer After Immune-Mediated Rejection of Melanoma Through a Shared Tumor Antigen

DOI: 10.1016/j.clgc.2011.12.002

Polly Gregor, Q. Daisy Huang, Humilidad F. Gallardo, Teresa S. Rasalan, Michael J. Morris et al. Short communication
(In Press Corrected Proof)
27 January 2012
Complete Response After Sequential Sunitinib-Sorafenib Treatment In a Patient With Renal Cell Carcinoma: A Case Report

DOI: 10.1016/j.clgc.2011.11.006

Elena Verzoni, Rodolfo Lanocita, Giuseppe Procopio Short communication
(In Press Corrected Proof)
09 January 2012
  • 1


Note to users: The section "Articles in Press" contains peer reviewed and accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated journal issue. Please be aware that "Articles in Press" do not have all bibliographic details available yet. There are three types of "Articles in Press":
  • Accepted Manuscripts: these are manuscripts that have been selected for publication. They have not been typeset and the text may change before final publication.
  • Uncorrected proofs: these are articles that are not yet finalized and that will be corrected by the authors. Therefore the text could change before final publication. Uncorrected proofs may be temporarily unavailable for production reasons.
  • Corrected proofs: these are articles containing the authors' corrections. The content of the article will usually remain unchanged, and possible further corrections are fairly minor. Typically the only difference with the finally published article is that specific issue and page numbers have not yet been assigned.